Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 140

1.

Late saphenous vein graft occlusion in patients with coronary bypass: possible role of aspirin resistance.

Yilmaz MB, Balbay Y, Caldir V, Ayaz S, Guray Y, Guray U, Korkmaz S.

Thromb Res. 2005;115(1-2):25-9.

PMID:
15567449
2.

Increased plasma beta-thromboglobulin in patients with coronary artery vein graft occlusion: response to low dose aspirin.

Gavaghan TP, Hickie JB, Krilis SA, Baron DW, Gebski V, Low J, Chesterman CN.

J Am Coll Cardiol. 1990 May;15(6):1250-8.

PMID:
2139442
3.

Association between paraoxonase activity and late saphenous vein graft occlusion in patients with coronary artery bypass grafting.

Cagirci G, Cay S, Karakurt O, Yazihan N, Aydin C, Acikel S, Dogan M, Kilic H, Topaloglu S, Aras D, Akdemir R.

Kardiol Pol. 2009 Oct;67(10):1063-8.

4.

Endothelial injury and acquired aspirin resistance as promoters of regional thrombin formation and early vein graft failure after coronary artery bypass grafting.

Poston RS, Gu J, Brown JM, Gammie JS, White C, Nie L, Pierson RN 3rd, Griffith BP.

J Thorac Cardiovasc Surg. 2006 Jan;131(1):122-30. Epub 2005 Dec 9.

5.

Saphenous vein graft patency 1 year after coronary artery bypass surgery and effects of antiplatelet therapy. Results of a Veterans Administration Cooperative Study.

Goldman S, Copeland J, Moritz T, Henderson W, Zadina K, Ovitt T, Doherty J, Read R, Chesler E, Sako Y, et al.

Circulation. 1989 Nov;80(5):1190-7.

PMID:
2680158
6.

Effects of antiplatelet therapy with indobufen or aspirin-dipyridamole on graft patency one year after coronary artery bypass grafting.

Rajah SM, Nair U, Rees M, Saunders N, Walker D, Williams G, Critchley A, Beton D, Campbell C, Lawson RA, et al.

J Thorac Cardiovasc Surg. 1994 Apr;107(4):1146-53.

PMID:
8159037
7.

Influence of aspirin and dipyridamole on patency of coronary artery bypass grafts.

Mayer JE Jr, Lindsay WG, Castaneda W, Nicoloff DM.

Ann Thorac Surg. 1981 Mar;31(3):204-10.

PMID:
7011226
8.

Placebo-controlled trial of enteric coated aspirin in coronary bypass graft patients. Effect on graft patency.

Hockings BE, Ireland MA, Gotch-Martin KF, Taylor RR.

Med J Aust. 1993 Sep 20;159(6):376-8.

PMID:
8377686
9.

Effect of high dose statin therapy on platelet function; statins reduce aspirin-resistant platelet aggregation in patients with coronary heart disease.

Tirnaksiz E, Pamukcu B, Oflaz H, Nisanci Y.

J Thromb Thrombolysis. 2009 Jan;27(1):24-8. Epub 2007 Oct 5.

PMID:
17917708
10.

Aspirin in coronary artery bypass surgery: new aspects of and alternatives for an old antithrombotic agent.

Zimmermann N, Gams E, Hohlfeld T.

Eur J Cardiothorac Surg. 2008 Jul;34(1):93-108. doi: 10.1016/j.ejcts.2008.03.023. Epub 2008 Apr 29. Review.

PMID:
18448350
11.

Relationship between elevated platelet volume and saphenous vein graft disease.

Tavil Y, Sen N, Yazici HU, Hizal F, Açikgöz SK, Turfan M, Cengel A.

Clin Invest Med. 2010 Jun 1;33(3):E161-7.

PMID:
20519094
12.

Relationship between the serum sCD40L level and aspirin-resistant platelet aggregation in patients with stable coronary artery disease.

Pamukcu B, Oflaz H, Onur I, Midilli K, Yilmaz G, Yilmaz E, Nisanci Y.

Circ J. 2008 Jan;72(1):61-6.

13.

The impact of intravenous aspirin administration on platelet aspirin resistance after on-pump coronary artery bypass surgery.

Bach J, Kammerer I, Isgro F, Haubelt H, Vogt A, Saggau W, Hellstern P.

Platelets. 2009 May;20(3):150-7. doi: 10.1080/09537100902780650.

PMID:
19437331
14.

Effect of dipyridamole and aspirin on late vein-graft patency after coronary bypass operations.

Chesebro JH, Fuster V, Elveback LR, Clements IP, Smith HC, Holmes DR Jr, Bardsley WT, Pluth JR, Wallace RB, Puga FJ, et al.

N Engl J Med. 1984 Jan 26;310(4):209-14.

PMID:
6361561
15.

Evaluation of serum levels of solubilized adhesion molecules in patients with aortocoronary saphenous vein grafts.

Aras D, Erbay AR, Maden O, Topaloglu S, Ozbakir C, Ozdemir O, Cagli K, Demir AD, Soylu M, Kisacik HL, Korkmaz S.

Coron Artery Dis. 2005 Nov;16(7):431-6.

PMID:
16205451
16.

Comparison of saphenous vein graft versus right gastroepiploic artery to revascularize the right coronary artery: a prospective randomized clinical, functional, and angiographic midterm evaluation.

Glineur D, Hanet C, Poncelet A, D'hoore W, Funken JC, Rubay J, Astarci P, Lacroix V, Verhelst R, Etienne PY, Noirhomme P, El Khoury G.

J Thorac Cardiovasc Surg. 2008 Aug;136(2):482-8. doi: 10.1016/j.jtcvs.2008.01.016. Epub 2008 May 19.

17.

Tranexamic acid and early saphenous vein graft patency in conventional coronary artery bypass graft surgery: a prospective randomized controlled clinical trial.

Karski J, Djaiani G, Carroll J, Iwanochko M, Seneviratne P, Liu P, Kucharczyk W, Fedorko L, David T, Cheng D.

J Thorac Cardiovasc Surg. 2005 Aug;130(2):309-14.

18.

Usefulness of aspirin resistance after percutaneous coronary intervention for acute myocardial infarction in predicting one-year major adverse coronary events.

Marcucci R, Paniccia R, Antonucci E, Gori AM, Fedi S, Giglioli C, Valente S, Prisco D, Abbate R, Gensini GF.

Am J Cardiol. 2006 Nov 1;98(9):1156-9. Epub 2006 Aug 31.

PMID:
17056317
19.

Arterial versus venous bypass grafts in patients with in-stent restenosis.

Gaudino M, Cellini C, Pragliola C, Trani C, Burzotta F, Schiavoni G, Nasso G, Possati G.

Circulation. 2005 Aug 30;112(9 Suppl):I265-9.

20.

[Factors determining late patency of aortobifemoral bypass graft].

Davidović LB, Lotina SI, Kostić DM, Cinara II, Cvetković SD, Stojanov PL, Velimirović DB, Marković MM, Pejkić SA, Vukotić AM.

Srp Arh Celok Lek. 1997 Jan-Feb;125(1-2):24-35. Serbian.

PMID:
17974352

Supplemental Content

Support Center